Reference ranges of 17-hydroxyprogesterone, DHEA, DHEAS, androstenedione, total and free testosterone determined by TurboFlow-LC-MS/MS and associations to health markers in 304 men

Clinica Chimica Acta

Volumn 454, Issue , 2016, Pages 82-88

  Damgaard Olesen, A ^a,b   Johannsen, T H ^a,b   Holmboe, S A ^a,b   Soeborg T ^a,b   Petersen, J H ^a   Andersson, A M ^a,b   Aadahl, M ^c,d,e   Linneberg, A ^c,d,e   Juul, A ^a,b,e  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Internat Center for Res and Res Training in Endocrine Disruption of Male Reprod and Child Hea   (Denmark)

^c GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^d Rigshospitalet   (Denmark)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Androgens; LC MS MS; Lifestyle factors; Metabolic syndrome; Reference range; Steroid metabolites

Indexed keywords

ANDROSTENEDIONE; HYDROXYPROGESTERONE; PRASTERONE; PRASTERONE SULFATE; TESTOSTERONE; BIOLOGICAL MARKER; SULFATE;

ADULT; AGE; ALCOHOL CONSUMPTION; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; BODY MASS; CLINICAL EXAMINATION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; HORMONE DETERMINATION; HUMAN; HUMAN EXPERIMENT; LIFESTYLE; LIQUID CHROMATOGRAPHY; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PHYSICAL ACTIVITY; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SMOKING HABIT; STEROID BLOOD LEVEL; TANDEM MASS SPECTROMETRY; VALIDATION PROCESS; YOUNG ADULT; BLOOD; NORMAL HUMAN;

17-ALPHA-HYDROXYPROGESTERONE; ADULT; ANDROSTENEDIONE; BIOMARKERS; BLOOD CHEMICAL ANALYSIS; CHROMATOGRAPHY, LIQUID; CROSS-SECTIONAL STUDIES; DEHYDROEPIANDROSTERONE; HEALTHY VOLUNTEERS; HUMANS; MALE; MIDDLE AGED; SULFATES; TANDEM MASS SPECTROMETRY; TESTOSTERONE;

EID: 84953431586     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2015.12.042     Document Type: Article

References (40)

1. Kushnir M.M., Blamires T., Rockwood A.L., Roberts W.L., Yue B., Erdogan E., et al. Liquid chromatography-tandem mass spectrometry assay for androstenedione, dehydroepiandrosterone, and testosterone with pediatric and adult reference intervals. Clin. Chem. 2010, 56:1138-1147. 10.1373/clinchem.2010.143222.
2. Ketha H., Kaur S., Grebe S.K., Singh R.J. Clinical applications of LC-MS sex steroid assays: evolution of methodologies in the 21st century. Curr. Opin. Endocrinol. Diabetes Obes. 2014, 21:217-226. 10.1097/MED.0000000000000068.
3. Faix J.D. Principles and pitfalls of free hormone measurements. Best Pract. Res. Clin. Endocrinol. Metab. 2013, 27:631-645. 10.1016/j.beem.2013.06.007.
4. Rosner W., Auchus R.J., Azziz R., Sluss P.M., Raff H. Position statement: utility, limitations, and pitfalls in measuring testosterone: an endocrine society position statement. J. Clin. Endocrinol. Metab. 2007, 92:405-413. 10.1210/jc.2006-1864.
5. Bhasin S., Pencina M., Jasuja G.K., Travison T.G., Coviello A., Orwoll E., et al. Reference ranges for testosterone in men generated using liquid chromatography tandem mass spectrometry in a community-based sample of healthy nonobese young men in the framingham heart study and applied to three geographically distinct cohorts. J. Clin. Endocrinol. Metab. 2011, 96:2430-2439. 10.1210/jc.2010-3012.
6. Fanelli F., Belluomo I., Di Lallo V.D., Cuomo G., De Iasio R., Baccini M., et al. Serum steroid profiling by isotopic dilution-liquid chromatography-mass spectrometry: comparison with current immunoassays and reference intervals in healthy adults. Steroids 2011, 76:244-253. 10.1016/j.steroids.2010.11.005.
7. Salameh W.a., Redor-Goldman M.M., Clarke N.J., Reitz R.E., Caulfield M.P. Validation of a total testosterone assay using high-turbulence liquid chromatography tandem mass spectrometry: total and free testosterone reference ranges. Steroids 2010, 75:169-175. 10.1016/j.steroids.2009.11.004.
8. Yeap B.B., Alfonso H., Chubb S.a.P., Handelsman D.J., Hankey G.J., Norman P.E., et al. Reference ranges and determinants of testosterone, dihydrotestosterone, and estradiol levels measured using liquid chromatography-tandem mass spectrometry in a population-based cohort of older men. J. Clin. Endocrinol. Metab. 2012, 97:4030-4039. 10.1210/jc.2012-2265.
9. Shiraishi S., Lee P.W.N., Leung A., Goh V.H.H., Swerdloff R.S., Wang C. Simultaneous measurement of serum testosterone and dihydrotestosterone by liquid chromatography-tandem mass spectrometry. Clin. Chem. 2008, 54:1855-1863. 10.1373/clinchem.2008.103846.
10. Turpeinen U., Linko S., Itkonen O., Hämäläinen E. Determination of testosterone in serum by liquid chromatography-tandem mass spectrometry. Scand. J. Clin. Lab. Invest. 2008, 68:50-57. 10.1080/00365510701496496.
11. Aadahl M., Zacho M., Linneberg A., Thuesen B.H., Jorgensen T. Comparison of the Danish step test and the watt-max test for estimation of maximal oxygen uptake: the Health2008 study. Eur. J. Prev. Cardiol. 2012, 10.1177/2047487312462825.
12. Byberg S., Hansen A.L.S., Christensen D.L., Vistisen D., Aadahl M., Linneberg A., et al. Sleep duration and sleep quality are associated differently with alterations of glucose homeostasis. Diabet. Med. 2012, 29:354-360. 10.1111/j.1464-5491.2012.03711.x.
13. WHO-definition BMI (11.18). http://www.cdc.gov/healthyweight/assessing/bmi/adult_bmi/.
14. Linneberg A., Gonzalez-Quintela A., Vidal C., Jørgensen T., Fenger M., Hansen T., et al. Genetic determinants of both ethanol and acetaldehyde metabolism influence alcohol hypersensitivity and drinking behaviour among Scandinavians. Clin. Exp. Allergy 2010, 40:123-130. 10.1111/j.1365-2222.2009.03398.x.
15. Søeborg T., Frederiksen H., Fruekilde P., Johannsen T.H., Juul A., Andersson A.M. Serum concentrations of DHEA, DHEAS, 17α-hydroxyprogesterone, δ4-androstenedione and testosterone in children determined by TurboFlow-LC-MS/MS. Clin. Chim. Acta 2013, 419:95-101. 10.1016/j.cca.2013.01.019.
16. Vermeulen A., Verdonck L., Kaufman J.M. A critical evaluation of simple methods for the estimation of free testosterone in serum. J. Clin. Endocrinol. Metab. 1999, 84:3666-3672. 10.1210/jcem.84.10.6079.
17. International diabetes federation (266 (1955) 134-137. doi: 10.1016/S0140-6736(55)92135-8). (11.18). http://www.idf.org/webdata/docs/IDF_Meta_def_final.pdfLancet.
18. Søeborg T., Frederiksen H., Mouritsen A., Johannsen T.H., Main K.M., Jørgensen N., et al. Sex, age, pubertal development and use of oral contraceptives in relation to serum concentrations of DHEA, DHEAS, 17α-hydroxyprogesterone, δ4-androstenedione, testosterone and their ratios in children, adolescents and young adults. Clin. Chim. Acta 2014, 437:6-13. 10.1016/j.cca.2014.06.018.
19. Kelsey T.W., Li L.Q., Mitchell R.T., Whelan A., Anderson R.A., Wallace W.H.B. A validated age-related normative model for male total testosterone shows increasing variance but no decline after age 40years. PLoS One 2014, 9. 10.1371/journal.pone.0109346.
20. Sartorius G., Spasevska S., Idan A., Turner L., Forbes E., Zamojska A., et al. Serum testosterone, dihydrotestosterone and estradiol concentrations in older men self-reporting very good health: the healthy man study. Clin. Endocrinol. 2012, 77:755-763. 10.1111/j.1365-2265.2012.04432.x.
21. Feldman H.A., Longcope C., Derby C.A., Johannes C.B., Araujo A.B., Coviello A.D., et al. Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts Male Aging Study. J. Clin. Endocrinol. Metab. 2002, 87:589-598. 10.1210/jc.87.2.589.
22. Andersson A.-M., Jensen T.K., Juul A., Petersen J.H., Jørgensen T., Skakkebaek N.E. Secular decline in male testosterone and sex hormone binding globulin serum levels in Danish population surveys. J. Clin. Endocrinol. Metab. 2007, 92:4696-4705. 10.1210/jc.2006-2633.
23. Bélanger A., Candas B., Dupont A., Cusan L., Diamond P., Gomez J.L., et al. Changes in serum concentrations of conjugated and unconjugated steroids in 40- to 80-year-old men. J. Clin. Endocrinol. Metab. 1994, 79:1086-1090. 10.1210/jcem.79.4.7962278.
24. Zhai G., Teumer A., Stolk L., Perry J.R.B., Vandenput L., Coviello A.D., et al. Eight common genetic variants associated with serum DHEAS levels suggest a key role in ageing mechanisms. PLoS Genet. 2011, 7:1-10. 10.1371/journal.pgen.1002025.
25. Büttler R.M., Martens F., Kushnir M.M., Ackermans M.T., Blankenstein M.A., Heijboer A.C. Simultaneous measurement of testosterone, androstenedione and dehydroepiandrosterone (DHEA) in serum and plasma using isotope-dilution 2-dimension ultra high performance liquid-chromatography tandem mass spectrometry (ID-LC-MS/MS). Clin. Chim. Acta 2015, 438:157-159. 10.1016/j.cca.2014.08.023.
26. Baulieu E.E., Thomas G., Legrain S., Lahlou N., Roger M., Debuire B., et al. Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution of the DHEAge study to a sociobiomedical issue. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:4279-4284. 10.1097/00006254-200011000-00018.
27. Moisan A.M., Ricketts M.L., Tardy V., Desrochers M., Mébarki F., Chaussain J.L., et al. New insight into the molecular basis of 3beta-hydroxysteroid dehydrogenase deficiency: identification of eight mutations in the HSD3B2 gene eleven patients from seven new families and comparison of the functional properties of twenty-five mutant enzymes. J. Clin. Endocrinol. Metab. 1999, 84:4410-4425. 10.1210/jcem.84.12.6288.
28. Aksglaede L., Andersson A.M., Jørgensen N., Jensen T.K., Carlsen E., McLachlan R.I., et al. Primary testicular failure in Klinefelter's syndrome: the use of bivariate luteinizing hormone-testosterone reference charts. Clin. Endocrinol. 2007, 66:276-281. 10.1111/j.1365-2265.2006.02722.x.
29. Camacho E.M., Huhtaniemi I.T., O'Neill T.W., Finn J.D., Pye S.R., Lee D.M., et al. Age-associated changes in hypothalamic-pituitary-testicular function in middle-aged and older men are modified by weight change and lifestyle factors: longitudinal results from the European male ageing study. Eur. J. Endocrinol. 2013, 168:445-455. 10.1530/EJE-12-0890.
30. Wu F.C.W., Tajar A., Pye S.R., Silman A.J., Finn J.D., O'Neill T.W., et al. Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European male aging study. J. Clin. Endocrinol. Metab. 2008, 93:2737-2745. 10.1210/jc.2007-1972.
31. Agergaard Holmboe S., Vradi E., Kold Jensen T., Linneberg A., Husemoen L.L.N., Scheike T., et al. The association of reproductive hormone levels and all-cause, cancer and cardiovascular disease mortality in men. J. Clin. Endocrinol. Metab. 2015, jc.2015-jc.2460. 10.1210/jc.2015-2460.
32. Brand J.S., van der Tweel I., Grobbee D.E., Emmelot-Vonk M.H., van der Schouw Y.T. Testosterone, sex hormone-binding globulin and the metabolic syndrome: a systematic review and meta-analysis of observational studies. Int. J. Epidemiol. 2011, 40:189-207. 10.1093/ije/dyq158.
33. Nielsen T.L., Hagen C., Wraae K., Brixen K., Petersen P.H., Haug E., et al. Visceral and subcutaneous adipose tissue assessed by magnetic resonance imaging in relation to circulating androgens, sex hormone-binding globulin, and luteinizing hormone in young men. J. Clin. Endocrinol. Metab. 2007, 92:2696-2705. 10.1210/jc.2006-1847.
34. Field A.E., Colditz G.A., Willett W.C., Longcope C., McKinlay J.B. The relation of smoking, age, relative weight, and dietary intake to serum adrenal steroids, sex hormones, and sex hormone-binding globulin in middle-aged men. J. Clin. Endocrinol. Metab. 1994, 79:1310-1316. 10.1210/jcem.79.5.7962322.
35. Travison T.G., Araujo A.B., Kupelian V., O'Donnell A.B., McKinlay J.B. The relative contributions of aging, health, and lifestyle factors to serum testosterone decline in men. J. Clin. Endocrinol. Metab. 2007, 92:549-555. 10.1210/jc.2006-1859.
36. Smith M.R. Changes in fat and lean body mass during androgen-deprivation therapy for prostate cancer. Urology 2004, 63:742-745. 10.1016/j.urology.2003.10.063.
37. Boehmer A.L., Brinkmann A.O., Sandkuijl L.A., Halley D.J., Niermeijer M.F., Andersson S., et al. 17beta-hydroxysteroid dehydrogenase-3 deficiency: diagnosis, phenotypic variability, population genetics, and worldwide distribution of ancient and de novo mutations. J. Clin. Endocrinol. Metab. 1999, 84:4713-4721. 10.1210/jcem.84.12.6174.
38. Noordam J.A.C., Dhir V., McNielis J.C., Smeitink, Smeets R., Sweep F.C.G.J. Inactivating PAPSS2 mutations in a patient with premature pubarche. Analysis 2009.
39. Isidori A.M., Caprio M., Strollo F., Moretti C., Frajese G., Isidori A., et al. Leptin and androgens in male obesity: evidence for leptin contribution to reduced androgen levels. J. Clin. Endocrinol. Metab. 1999, 84:3673-3680. 10.1210/jcem.84.10.6082.
40. Vermeulen A., Kaufman J.M., Deslypere J.P., Thomas G. Attenuated luteinizing hormone (LH) pulse amplitude but normal LH pulse frequency, and its relation to plasma androgens in hypogonadism of obese men. J. Clin. Endocrinol. Metab. 1993, 76:1140-1146. 10.1210/jc.76.5.1140.